icometrix

Founded in 2011, icometrix, now a GE HealthCare Company, (Leuven, Belgium | Boston, MA, USA) strives for data-driven insights and personalized patient care, supported by AI. icometrix offers a portfolio of eight regulatory approved AI solutions to assist healthcare with various challenges; icobrain extracts data from brain MRI and CT scans for the radiological reporting and clinical management of neurological disorders such as multiple sclerosis, brain trauma, epilepsy, stroke, dementia, and Alzheimer's disease. icompanion, a digital platform, and mobile app helps people with MS and their care team to monitor clinical symptoms and treatments efficiently and objectively. Today, icometrix is internationally active and integrated into more than 330 clinical sites. In addition, icometrix supports pharmaceutical companies in phase I-III trials as well as in Real-World Evidence (RWE) studies through imaging and data services, and digital health strategy.